Highlights from CTOS 2024 Annual Meeting

The 2024 Connective Tissue Oncology Society (CTOS) Annual Meeting was held from November 13-16, at the Manchester Grand Hyatt in San Diego, California.

This event venue provided a setting for thought leaders, researchers, and clinicians from around the world to convene and exchange ideas on the latest advances in connective tissue oncology.

The Connective Tissue Oncology Society (CTOS) was formed in 1995 and incorporated in 1997. It is an international group of physicians and scientists with a shared primary interest in tumors of connective tissues.

The society’s mission is to advance the care of patients with connective tissue tumors and to expand knowledge of these tumors’ biology, encompassing both basic and clinical research.

A highlight of the meeting was the 2024 Gala, hosted aboard the historic USS Midway Museum, a decommissioned aircraft carrier turned iconic landmark.

Herbert Loong:

“Look at how the CTOS2024 is being sported by David Gyorki, TARPSWG, Peter Mac Cancer Centre! Smart Casual is the way to go for his long journey back to Australia. Thanks everyone for a wonderful meeting!”

Priya Chudasama:

“It starts! CTOS2024 is officially underway with a helluva welcome address by Jason Sicklick and President Damon Reed, also featuring a special guest! Wishing all the top guns of sarcoma a great meeting!”

Ahsan Farooqi:

“Great debate this morning about whether hypofrac RT regimens can be accepted as SOC in the management of STS. ICYMI – emerging data is encouraging but significant concerns re: long-term toxicities remain!”

Fantine Giap:

“Honored to present long term results of dose escalation with proton therapy for BOS / C spine chordoma (PROG 85-26) at CTOS2024. Incredible dedication to patients with median follow up of 24 years.”

Denisse Evans:

“Grateful to CTOS for bringing the sarcoma community together. It’s always a privilege to learn, share, and connect with the amazing sarcoma community. Shout out to Sara Rothschild for leading the way in advocacy and research.”

Stefano Tosta:

“Great talk at CTOS2024 by Everett Moding on personalized ctDNA monitoring for patients with STS receiving XRT with or without Pembro! Exciting opportunity to better identify patients benefiting from pre-op IO in STS.”

Herbert Loong:

“Kicking off GIST session at CTOS2024 with novel treatment approaches including novel TKIs, combination of checkpoint inhibitors and VEGFRi as well as taking an ‘n of 1’ approach with molecular profiling and appropriate resistance mechanisms.”

Marco Fiaro:

“CTOS2924 Progression / spontaneous regression in desmoid on active surveillance may be related to altereted immune profiles in peripheral blood – stimulating insight from Sandro Pasquali.”

Heather Lyu:

“Congratulations Ian Folkert on a fantastic podium presentation at CTOS! Looking forward to more animated discussions at future sarcoma meetings.”

Sara Danielli:

“So grateful for being awarded with the Young Investigator Award from CTOS!

Such a great time in San Diego presenting a collaborative study with Langenau Lab, Claudia Yun Wei and Anand Patel, making new friends, and celebrating at the USSMidwayMuseum”

Pawel Sobczuk:

“IDRX-42 a novel KIT TKI (targeting KIT ex 9, 11, 13 and 17 mut.) shows promising activity in phase I STRATEGIST 1 trial in pts with 2+ line of therapy

ORR 29%, 53% in 2nd line
great presentation by Suzanne George.”

Michael Wagner:

“Doxorubicin +/- pembro trial open now! Saw some impressive activity in the initial phase2, hopefully will be confirmed!”

Anna M. Czarnecka:

“Patrick Schöffski on MDM2 inhibitor Brigimadlin in ddLPS sarcoma during CTOS2024

Boehringer Ingelheim inducing hot discussion.”

Homma Khosroyani:

“Thank you CTOS for allowing me to present my work again this year. I’m so honored to receive the best GIST poster award! Thank you to Dr. Heinrich for your mentorship and to our awesome collaborators like Sebastian Bauer and The Life Raft Group!”

Andrea Franza:

“Postcards from CTOS2024 day2: opening ceremony, a great presentation by Stefano Radaelli for SACRO study and some good talks at poster reception at the end of the day.”

Hannah Abrams:

“Conversations in San Diego elevator this week:

1: Did you know there’s a liver meeting here too?
2: Oh, no, cool!
3: Wait… you guys aren’t here for the liver meeting?

Glad the convergence of CTOS2024 and TLM24 let me catch Dilara Hatipoglu!”

Priya Chudasama:

“Thank you CTOS2024 organizing committees for the opportunity to present our project on uncovering fusion oncoprotein-specific E3ligases for TPD approaches, performed by our MD candidate Kilian Bales in collab with Mikołaj Słabicki, Sebastian Bauer, Dominic Helm & team DKFZ, Proteomics Core Facility Stefan Frohling and many others! Thank you Nezha Benabdallah for the capture.”

Luna de Sutter:

“Thank you CTOS for inspiring us yet again with interesting talks, debates and posters. It is always great to connect with sarcoma dedicated people, this time while enjoying the beautiful San Diego.”

Marco Fiore:

“CTOS2024 coming to an end with Stefano Radaelli, Rosalba Miceli, Daniela Salvatore farewell seafood lunch after caching up again with travelling surgeon Catherine Sarre.”

Andrea Franza:

“Wrapping up last day of CTOS2024! Again, so many interesting presentations, a fantastic crew of colleagues/friends and a super sunset to say goodbye to SD.”

Anand Raja:

“Grateful to have attended CTOS2024 in San Diego, where I presented and received a travel grant. A great opportunity to learn and connect with others in the field! Excited to bring back new insights.”

For more posts like this visit oncodaily.com